Drug
Otp 01
Otp 01: highest development phase Phase 1/2, developed by Ottimo Pharma Limited. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Ottimo Pharma Limited
Trials
| Drug | Phase | Indication |
|---|---|---|
| OTP-01 NCT07266428 | Phase 1/2 | Advanced Solid Tumors |
Latest
No recent events.
Follow Otp 01 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.